A look at where Aetna is seeing value-based care success in Medicare Advantage
Aetna is seeing its value-based care efforts pay off in both preventive care metrics and cost savings, according to a new analysis from the company.
Aetna has observed significant value-based care success in Medicare Advantage, according to a recent analysis. The insurer compared outcomes across 20 measures for individuals in its Medicare Advantage plans under value-based models and fee-for-service, finding that the value-based arrangements outperformed fee-for-service in 17 of the included measures.
For instance, value-based care models had 43% more members control their HbA1C and 34% more had controlled blood pressure compared to fee-for-service. Additionally, there were 20% more patients screened for colorectal cancer and 7% fewer hospitalizations under value-based care. Aetna's chief medical officer, Dr. Ali Khan, noted that these models are particularly successful in managing difficult metrics, such as blood sugar levels.
Dr. Khan attributed this success to providers who are taking on greater risk in managing costs and outcomes. He emphasized the importance of focusing on the total cost of care rather than just avoiding hospital stays. Khan also highlighted the need for a multi-year commitment to value-based care and the integration of interoperability and care management tools to support this shift.
Written by urgent.news from Fierce Healthcare's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
